Regional Sites Contact Us ORAL DOSE BIOLOGICS SPECIALTY CLINICAL SUPPLY CONSUMER EXPERT CONTENT LOCATIONS ABOUT US CAREERS INVESTOR RELATIONS Loading ... Investor Center Home INVESTORS Catalent Inc. (NYSE: CTLT), an S&P 500® company, is the leading global provider of development sciences and manufacturing platforms for medicines, including biotherapeutics; cell and gene therapies; and consumer health products. With almost 90 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance, and ensuring reliable global clinical and commercial product supply. Catalent’s workforce exceeds 17,000 people, including more than 2,500 scientists and technicians, at more than 50 facilities on four continents, and in fiscal year 2021, it generated $4 billion in annual revenue. LATEST FINANCIAL NEWS Loading ... VIEW ALL NEWS FEATURED PRESENTATION 11/02/2021 CTLT FY22 Q1 Earnings Call Presentation DOWNLOAD PDF (OPENS IN NEW WINDOW) VIEW ALL PRESENTATIONS LATEST EVENTS Loading ... VIEW ALL EVENTS CONTACT US Investor Relations Dept Catalent, Inc. 14 Schoolhouse Road Somerset, NJ 08873 Phone: +1 732 537 6325 Fax: +1 732 537 5932 Mail: investors@catalent.com QUICK LINKS SEC FILINGS INVESTOR FAQS INFORMATION REQUEST FORM INVESTOR EMAIL ALERTS News Events & Presentations Quarterly Reports Annual Reports SEC Filings End of Day Stock Quote SIGN UP UNSUBSCRIBE Follow Us. Share Us. Expert Content Subscribe Investors Careers Contact Us Site Map By using this website you understand and accept that Catalent tracks your website activities to be able to offer you a more tailored response or information to meet your requirements, and that your personal data will be held in accordance with our Privacy Policy | Privacy Shield Statement. Terms | Modern Slavery Statement Copyright 2020, Catalent, Inc - All Rights Reserved Powered By Q4 Inc. 5.56.0.1 (opens in new window)